PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-53.88%
Negative revenue growth while ECL.AX stands at 50.60%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.32%
Negative gross profit growth while ECL.AX is at 54.70%. Joel Greenblatt would examine cost competitiveness or demand decline.
118.21%
EBIT growth above 1.5x ECL.AX's 1.44%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
118.21%
Operating income growth above 1.5x ECL.AX's 1.44%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
26.49%
Slight or no buybacks while ECL.AX is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
60.93%
Slight or no buyback while ECL.AX is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
130.13%
Positive OCF growth while ECL.AX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-46.67%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
188.14%
10Y revenue/share CAGR above 1.5x ECL.AX's 41.14%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
4125.22%
5Y CAGR of 4125.22% while ECL.AX is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
No Data
No Data available this quarter, please select a different quarter.
129.75%
Positive long-term OCF/share growth while ECL.AX is negative. John Neff would see a structural advantage in sustained cash generation.
148.45%
OCF/share CAGR of 148.45% while ECL.AX is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
No Data
No Data available this quarter, please select a different quarter.
-5.76%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
No Data
No Data available this quarter, please select a different quarter.
141.41%
3Y net income/share CAGR of 141.41% while ECL.AX is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
382.46%
R&D growth of 382.46% while ECL.AX is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
89.07%
SG&A growth well above ECL.AX's 52.07%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.